Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects - Trial NCT06221800
Access comprehensive clinical trial information for NCT06221800 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Irvine and is currently Recruiting. The study focuses on Non Small Cell Lung Cancer. Target enrollment is 82 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, Irvine
Timeline & Enrollment
N/A
Jan 31, 2024
Dec 01, 2025
Primary Outcome
Gut microbiomes in advanced/metastatic NSCLC patients
Summary
This is a pilot study collecting data on the diversity and composition of gut microbiomes in
 subjects with advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) while receiving
 treatment for NSCLC.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06221800
Non-Device Trial